C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07K 14/015 (2006.01) C07K 16/08 (2006.01) C12Q 1/70 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2175256
The present invention relates to a method of detecting a causative agent of the so-called spontaneous early abortion by investigating patients' samples for the presence of adeno-associated virus DNA (AAV DNA), or AAV antigen or antibodies, preferably of the IgM type, directed to AAV. Furthermore, the present invention relates to antibodies suitable for said method.
La présente invention se rapporte à un procédé de détection d'un agent impliqué dans l'avortement dit précoce et spontané, consistant à examiner des échantillons prélevés de patients afin d'y détecter la présence d'ADN de virus adéno-associé (AAV-DNA) ou d'un antigène d'AAV, ou d'anticorps, de préférence du type IgM, dirigés contre l'AAV. La présente invention se rapporte également à des anticorps convenant à un tel procédé.
Geletneky Karsten
Kern Andrea
Kleinschmidt Jurgen
Rabreau Michele
Schlehofer Jorg
Arkin Gary
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Recht
LandOfFree
Adeno-associated virus - its diagnostic use with early abortion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated virus - its diagnostic use with early abortion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus - its diagnostic use with early abortion will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1735490